Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting ideal oral vaccine vectors based on probiotics: a systematical view
Boyu Jiang, Qiang Li, Bingming Ou, et al.
Applied Microbiology and Biotechnology (2019) Vol. 103, Iss. 10, pp. 3941-3953
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Lactic acid bacteria: Nature, Characterization, Mode of action, Products and Applications
Patrick Othuke Akpoghelie, Great Iruoghene Edo, Ali B.M. Ali, et al.
Process Biochemistry (2025)
Closed Access | Times Cited: 3
Engineering probiotics for therapeutic applications: recent examples and translational outlook
Nikhil Aggarwal, Amy M. Ehrenworth Breedon, Christina M. Davis, et al.
Current Opinion in Biotechnology (2020) Vol. 65, pp. 171-179
Closed Access | Times Cited: 108
Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota
Yiqiu Fei, Zuobing Chen, Shengyi Han, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 8, pp. 1037-1054
Closed Access | Times Cited: 68
Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 46
Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review
Zahra Zahedifard, Shirin Mahmoodi, Abdolmajid Ghasemian
Biotechnology and Applied Biochemistry (2025)
Closed Access | Times Cited: 1
A cross talk between the immunization and edible vaccine: Current challenges and future prospects
Ankit Sahoo, Ashok Kumar Mandal, Khusbu Dwivedi, et al.
Life Sciences (2020) Vol. 261, pp. 118343-118343
Open Access | Times Cited: 40
The oral antigen-adjuvant fusion vaccine P-MCP-FlaC provides effective protective effect against largemouth bass ranavirus infection
Qian Liu, Xingchen Huo, Qingqing Tian, et al.
Fish & Shellfish Immunology (2023) Vol. 142, pp. 109179-109179
Closed Access | Times Cited: 14
Probiotics as multifaceted oral vaccines against colon cancer: A review
Shubhi Singh, Manisha Singh, Smriti Gaur
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice
Giovanni Sarnelli, Alessandro Re, Marcella Pesce, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 569-569
Open Access | Times Cited: 11
Oral vaccination with a recombinant Lactobacillus plantarum expressing the Eimeria tenella rhoptry neck 2 protein elicits protective immunity in broiler chickens infected with Eimeria tenella
Tongxuan Zhang, Hangfan Qu, Wei Zheng, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
A new vaccination approach for Salmonellosis employing a multi-epitope vaccine based on live microbial cell factory from Lactococcus lactis
Reyhaneh Sadat Moosavi-Kohnehsari, Mahnaz Jafari-Sohi, Tohid Piri-Gharaghie, et al.
Poultry Science (2025) Vol. 104, Iss. 2, pp. 104789-104789
Open Access
Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines
Allison C. Vilander, Gregg A. Dean
Vaccines (2019) Vol. 7, Iss. 4, pp. 150-150
Open Access | Times Cited: 32
Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development
Naheed Mojgani, Youcef Shahali, Maryam Dadar
Beneficial Microbes (2020) Vol. 11, Iss. 3, pp. 213-226
Closed Access | Times Cited: 29
Construction and evaluation of recombinant Lactobacillus plantarum NC8 delivering one single or two copies of G protein fused with a DC-targeting peptide (DCpep) as novel oral rabies vaccine
Jianzhong Wang, Haoyan Jiang, Rui Yang, et al.
Veterinary Microbiology (2020) Vol. 251, pp. 108906-108906
Closed Access | Times Cited: 28
The Immunomodulatory Effects and Applications of Probiotic Lactiplantibacillus plantarum in Vaccine Development
Guiting He, Huanbing Long, Jiarong He, et al.
Probiotics and Antimicrobial Proteins (2024) Vol. 16, Iss. 6, pp. 2229-2250
Closed Access | Times Cited: 3
Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases
Nabendu Debnath, Pooja Yadav, Praveen Kumar Mehta, et al.
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 1, pp. 100-117
Closed Access | Times Cited: 8
Could Probiotics and Postbiotics Function as “Silver Bullet” in the Post-COVID-19 Era?
Svetoslav Dimitrov Todorov, John Tagg, И. Иванова
Probiotics and Antimicrobial Proteins (2021) Vol. 13, Iss. 6, pp. 1499-1507
Open Access | Times Cited: 16
Engineered Recombinant Escherichia coli Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy in Vivo
Bingming Ou, Boyu Jiang, Duo Jin, et al.
ACS Synthetic Biology (2020) Vol. 9, Iss. 2, pp. 412-426
Closed Access | Times Cited: 17
Oral vaccination of fish against vibriosis using spore-display technology
Gabriela Gonçalves, Rafaela A. Santos, Filipe Coutinho, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Strategies for Enhancement of Live-Attenuated Salmonella-Based Carrier Vaccine Immunogenicity
James E. Galen, Rezwanul Wahid, Amanda D. Buskirk
Vaccines (2021) Vol. 9, Iss. 2, pp. 162-162
Open Access | Times Cited: 14
Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route
Seo-Ho Oh, Sunghee Kim, Ji-Hye Jeon, et al.
Vaccine (2021) Vol. 39, Iss. 30, pp. 4072-4081
Closed Access | Times Cited: 14
Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant Bacillus subtilis Spores Expressing SARS-CoV-2 Spike Protein with Natural Products
Ben Chung-Lap Chan, Peiting Li, Miranda Sin‐Man Tsang, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4996-4996
Open Access | Times Cited: 5
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice
Giovanni Sarnelli, Alessandro Re, Irene Palenca, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116441-116441
Open Access | Times Cited: 1
Bacillus subtilis Expressing the Infectious Pancreatic Necrosis Virus VP2 Protein Retains Its Immunostimulatory Properties and Induces a Specific Antibody Response
Félix Docando, Noelia Nuñez-Ortiz, Gabriela Gonçalves, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
TonB-Dependent Receptor Protein Displayed on Spores of Bacillus subtilis Stimulates Protective Immune Responses against Acinetobacter baumannii
NorAziyah MatRahim, Kathryn M. Jones, Brian Keegan, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1106-1106
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top